Innovacell Inc.TSE: 504A

Announcement Regarding Completion of FDA IND Review and Approval to Include U.S. Sites and Patients in the ICEF15 Multi-Regional Phase III Trial

· Issued by Innovacell Inc. via TDnet

Innovacell Inc. (504A) Press Release

View Attachment